Luminescent AIE Dots for Anticancer Photodynamic Therapy

Area of Science:

• Biomedical Engineering
• Materials Science
• Oncology

Background:

• Photodynamic therapy (PDT) is an advanced cancer treatment modality with advantages over conventional therapies.
• Photosensitizers (PSs) are crucial for PDT, converting light into reactive oxygen species (ROS) to eliminate cancer cells.
• Aggregation-caused quenching (ACQ) is a limitation for traditional fluorescent dyes used as PSs.

Purpose of the Study:

• To review recent advancements in molecular design of aggregation-induced emission (AIE) based photosensitizers (PSs) and AIE dots.
• To highlight the application of AIE PSs and AIE dots in enhancing anticancer PDT.
• To discuss the theranostic potential of AIE-based probes in cancer treatment.

Main Methods:

• Review of recent scientific literature on AIE photosensitizers and AIE dots for PDT.
• Analysis of molecular design strategies for improved AIE PSs and AIE dots.
• Evaluation of the performance of AIE-based probes in ROS generation and cancer treatment models.

Main Results:

• AIE characteristics enable PSs to overcome ACQ, leading to efficient ROS generation at high concentrations or in aggregated states.
• AIE dots offer enhanced ROS production and simultaneous imaging capabilities for precise cancer therapy.
• Novel molecular designs of AIE PSs and AIE dots demonstrate significant potential for improved anticancer PDT efficacy.

Conclusions:

• AIE PSs and AIE dots represent a significant breakthrough in developing next-generation photosensitizers for cancer therapy.
• These materials offer a versatile platform for enhanced, localized cancer treatment with reduced side effects.
• The integration of AIE properties into PSs and nanomaterials paves the way for advanced theranostic applications in oncology.